KaveetaParikhVasishtMDPharmD

Diabetes, Lipid Metabolism

Associate Commissioner, Director-FDA Office of Women’s Health.

Dr. Vasisht is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2010
University of ChicagoResidency, Internal Medicine, 2003 - 2006
Rutgers Robert Wood Johnson Medical SchoolClass of 2003

PubMed

18 citations
Enhancing Diversity and Inclusion in Clinical Trials.
Amy Corneli, Emily Hanlen-Rosado, Kevin McKenna, Richardae Araojo, Dawn Corbett
Clinical Pharmacology and Therapeutics. 2023-03-01
8 citations
Eligibility criteria and clinical trials: An FDA perspective
Mili Duggal, Leonard Sacks, Kaveeta P. Vasisht
Contemporary Clinical Trials. 2021-07-27
41 citations
Limitations of metformin use in patients with kidney disease: are they warranted?
K. P. Vasisht, S. C. Chen, Y. Peng, George L. Bakris
Diabetes, Obesity & Metabolism. 2010-12-01

Journal Articles

Progress and opportunities for women in clinical trials: A look at recent data and initiatives from the U.S. FDA
Kaveeta P. Vasisht, Bridget M. Nugent, Janet Woodcock, Med, 5/14/2021